In samples from RRMS patients we observed a downregulation of GPX4 mRNA to 65 ± 17% compared to healthy controls (100 ± 24%), whereas HMOX mRNA was not regulated in MS (96 ± 16%) (Fig. 5d). Here, GPX4 is linked to myeloid sarcoma.